RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: osteoporosis
Accession: DOID:11476
browse the term
Definition: A bone resorption disease characterized by decreased density of normally mineralized bone which results_in the thinning of bone tissue and decreased mechanical strength. (DO)
Synonyms: exact_synonym: Osteoporoses; age related osteoporosis; age-related bone loss; age-related bone losses; age-related osteoporoses; involutional osteoporosis; post-traumatic osteoporoses; post-traumatic osteoporosis; senile osteoporoses; senile osteoporosis
narrow_synonym: LRP5-RELATED PRIMARY OSTEOPOROSIS
broad_synonym: WNT1-RELATED CONDITION
related_synonym: FRACTURE, HIP, SUSCEPTIBILITY TO; OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO; OSTEOPOROSIS, SUSCEPTIBILITY TO
primary_id: MESH:D010024
alt_id: OMIM:166710
xref: EFO:0003882 ; ICD10CM:M81.0 ; ICD9CM:733.0 ; NCI:C3298
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abl1
c-abl oncogene 1, non-receptor tyrosine kinase
IMP
RGD
PMID:10700189
RGD:10047094
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
G
Ace
angiotensin I converting enzyme
ISO
associated with Hypertension
RGD
PMID:19590507
RGD:2325225
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Actg1
actin, gamma, cytoplasmic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr11:120,236,513...120,239,321
Ensembl chr11:120,236,516...120,239,368
G
Adcy5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18029912
NCBI chr16:34,974,933...35,126,108
Ensembl chr16:34,975,247...35,126,108
G
Ager
advanced glycosylation end product-specific receptor
IEP ISO
mRNA:increased expression:proximal end of left femur (rat)
RGD
PMID:21542009 PMID:22036861
RGD:6767561 , RGD:7245948
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Alpl
alkaline phosphatase, liver/bone/kidney
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:3174660 PMID:10679946 PMID:19500388 PMID:25741868 PMID:28492532 PMID:29236161 PMID:32973344 More...
NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
G
Antxr2
anthrax toxin receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12973667
NCBI chr 5:98,032,547...98,178,876
Ensembl chr 5:98,030,642...98,178,902
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Ar
androgen receptor
treatment
ISO IDA
RGD
PMID:14600402 PMID:18847323
RGD:10043196 , RGD:10043198
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 1:71,596,315...71,618,562
Ensembl chr 1:71,596,309...71,618,790
G
Atm
ataxia telangiectasia mutated
IMP
RGD
PMID:16644862
RGD:10047420
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Atp4b
ATPase, H+/K+ exchanging, beta polypeptide
treatment
IMP
RGD
PMID:26869358
RGD:14696735
NCBI chr 8:13,436,209...13,446,778
Ensembl chr 8:13,436,205...13,446,825
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bglap
bone gamma carboxyglutamate protein
susceptibility
ISO
DNA:SNP, haplotype:promoter:g.-298C>T (human) associated with Diabetes Mellitus, type 2;associated with Diabetes Mellitus, type 2; protein:uncercarboxylated:serum
RGD
PMID:21550389 PMID:23137636 PMID:15108065
RGD:6483552 , RGD:10045665 , RGD:6483579
NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771
G
Bmp2
bone morphogenetic protein 2
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805
G
Bmp4
bone morphogenetic protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36453845
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
G
Calca
calcitonin/calcitonin-related polypeptide, alpha
ISO
RGD
PMID:2502220
RGD:734677
NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
G
Calcr
calcitonin receptor
susceptibility
ISO
DNA:SNP:cds:g.1340T>C (human) CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:23137636
RGD:10045665
NCBI chr 6:3,685,678...3,764,713
Ensembl chr 6:3,685,680...3,764,714
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:122,752,841...122,779,869
Ensembl chr 4:122,752,840...122,779,849
G
Car2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830
G
Cct2
chaperonin containing TCP1 subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr10:116,886,902...116,899,757
Ensembl chr10:116,886,906...116,899,719
G
Ciita
class II transactivator
IAGP
OMIM:166710
MouseDO
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
G
Clec11a
C-type lectin domain family 11, member a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27976999
NCBI chr 7:43,953,190...43,956,383
Ensembl chr 7:43,952,111...43,956,326
G
Col1a1
collagen, type I, alpha 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: OSTEOPOROSIS, INVOLUTIONAL | ClinVar Annotator: match by term: Osteoporosis ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18 | ClinVar Annotator: match by term: OSTEOPOROSIS, INVOLUTIONAL associated with Beta-Thalassemia;DNA:SNP:intron:g.2046G>T (human) DNA:SNP, haplotype:intron:g.2046G>T (human)
OMIM CTD ClinVar RGD
PMID:2037280 PMID:2542316 PMID:7695699 PMID:7942841 PMID:8218237 PMID:8408653 PMID:8456808 PMID:8613526 PMID:8669434 PMID:8808594 PMID:9016532 PMID:9067755 PMID:9295084 PMID:9443882 PMID:9536098 PMID:10739762 PMID:10931857 PMID:11113887 PMID:11317364 PMID:12362985 PMID:12590186 PMID:15024692 PMID:15024745 PMID:15241796 PMID:15741671 PMID:15864348 PMID:15931785 PMID:16199547 PMID:17078022 PMID:17211858 PMID:17309652 PMID:17392686 PMID:17576681 PMID:18272325 PMID:18412368 PMID:18553566 PMID:18704262 PMID:18996919 PMID:19344236 PMID:19358256 PMID:19491628 PMID:20981092 PMID:21249479 PMID:21567126 PMID:21594610 PMID:21667357 PMID:22206639 PMID:22589248 PMID:22753364 PMID:22855962 PMID:23265383 PMID:23587214 PMID:23692737 PMID:24390061 PMID:24767406 PMID:25086671 PMID:25597651 PMID:25741868 PMID:25944380 PMID:25963598 PMID:26177859 PMID:26467025 PMID:26627451 PMID:27044453 PMID:27132807 PMID:27146342 PMID:27509835 PMID:27510842 PMID:27519266 PMID:27748872 PMID:28102596 PMID:28378289 PMID:28492532 PMID:28725987 PMID:28810924 PMID:29499418 PMID:29595812 PMID:30614853 PMID:30692697 PMID:30715774 PMID:31304589 PMID:31447884 PMID:32166892 PMID:33228694 PMID:33928192 PMID:33939306 PMID:19143970 PMID:23137636 More...
RGD:11041180 , RGD:10045665
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col1a2
collagen, type I, alpha 2
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: OSTEOPOROSIS, INVOLUTIONAL | ClinVar Annotator: match by term: Osteoporosis
OMIM CTD ClinVar
PMID:1978725 PMID:2985635 PMID:7695699 PMID:7860070 PMID:8094076 PMID:8218237 PMID:9016532 PMID:9272740 PMID:9399846 PMID:9594376 PMID:9923651 PMID:15172002 PMID:16705691 PMID:16786509 PMID:17078022 PMID:18028452 PMID:19344236 PMID:21520333 PMID:22589248 PMID:25326637 PMID:25450603 PMID:25741868 PMID:25944380 PMID:26264438 PMID:26307460 PMID:26371943 PMID:26432670 PMID:26467025 PMID:26604951 PMID:27011056 PMID:27519266 PMID:28017821 PMID:28492532 PMID:29150909 PMID:30283887 PMID:30821104 PMID:32659730 More...
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Ctsk
cathepsin K
IMP
RGD
PMID:10469835
RGD:734856
NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
RGD
PMID:29882473
RGD:14700776
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
ISO
DNA:snps:multiple (human)
RGD
PMID:17002564
RGD:1625350
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO
DNA:snps:multiple (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20723554 PMID:17002564
RGD:1625350
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22337913
NCBI chr 2:170,324,877...170,339,065
Ensembl chr 2:170,324,628...170,339,065
G
Daam2
dishevelled associated activator of morphogenesis 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30598549
NCBI chr17:49,763,050...49,871,517
Ensembl chr17:49,763,050...49,871,371
G
Dbp
D site albumin promoter binding protein
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 7:45,354,658...45,359,579
Ensembl chr 7:45,354,512...45,359,627
G
Dspp
dentin sialophosphoprotein
ISO
protein:decreased expression:incisor dental pulp (rat)
RGD
PMID:23974864
RGD:12911019
NCBI chr 5:104,318,569...104,327,993
Ensembl chr 5:104,318,578...104,327,993
G
Eno1
enolase 1, alpha non-neuron
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336
G
Ercc1
excision repair cross-complementing rodent repair deficiency, complementation group 1
IMP
RGD
PMID:23281008
RGD:10045609
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
G
Esr1
estrogen receptor 1 (alpha)
no_association treatment
ISO IEP
DNA:SNP:intron:397T>C (human) DNA:repeat:5' utr:g.-1174(TA)10-27 (human) DNA:SNP:exon:2014G>A (human) DNA:repeat:intron:IVS5+225(CA)18-25 (human) DNA:SNPs:intron: (rs2234693, rs9340799) (human) DNA:SNP, haplotype:intron:g.938C>T (human)
RGD
PMID:23137636 PMID:21421090 PMID:17953702 PMID:17953702 PMID:10773580 PMID:16955786 PMID:17896124 PMID:20116372 PMID:16530497 More...
RGD:10045665 , RGD:10045841 , RGD:10045839 , RGD:10045839 , RGD:10045834 , RGD:8694129 , RGD:10045828 , RGD:10045826 , RGD:10045825
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
susceptibility treatment
ISO IEP
DNA:SNP, haplotypes: :-1213T>C (human) DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:repeat:3' utr: g.dupCA (human)
RGD
PMID:16777502 PMID:21421090 PMID:16530497 PMID:16955786 PMID:22948905
RGD:1626507 , RGD:10045841 , RGD:10045825 , RGD:8694129 , RGD:7364765
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Esrra
estrogen related receptor, alpha
IMP
RGD
PMID:19936213
RGD:10401868
NCBI chr19:6,888,345...6,899,182
Ensembl chr19:6,888,345...6,899,208
G
Fbn1
fibrillin 1
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868
NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913
G
Fga
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Fgb
fibrinogen beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
G
Gh
growth hormone
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:1466160
RGD:10003132
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
G
Ghr
growth hormone receptor
treatment
ISO
associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast associated with Cholestasis
RGD
PMID:17647196 PMID:19424739
RGD:10003128 , RGD:10003131
NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974
G
Golm1
golgi membrane protein 1
treatment
IMP ISO
protein:increased expression:serum
RGD
PMID:30396165 PMID:30396165
RGD:401827113 , RGD:401827113
NCBI chr13:59,782,810...59,823,598
Ensembl chr13:59,782,440...59,823,625
G
Gorab
golgin, RAB6-interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18997784
NCBI chr 1:163,212,472...163,231,238
Ensembl chr 1:163,212,477...163,231,238
G
Gpc6
glypican 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869591
NCBI chr14:117,162,332...118,216,941
Ensembl chr14:117,162,727...118,213,956
G
Gpd2
glycerol phosphate dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 2:57,127,690...57,260,731
Ensembl chr 2:57,127,647...57,260,731
G
Gpx1
glutathione peroxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gsn
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
G
Gsr
glutathione reductase
ISO
protein:decreased expression:blood
RGD
PMID:19464221
RGD:10401828
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstp1
glutathione S-transferase, pi 1
ISO
associated with Cystic Fibrosis;DNA:missense mutation:cds:c.313A>G (p.I105V) (human)
RGD
PMID:24593045
RGD:10401929
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Hfe
homeostatic iron regulator
IMP
associated with hemochromatosis
RGD
PMID:26829642
RGD:14746963
NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
G
Id4
inhibitor of DNA binding 4
IAGP
OMIM:166710
MouseDO
NCBI chr13:48,414,592...48,419,504
Ensembl chr13:48,414,704...48,419,502
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Ifngr1
interferon gamma receptor 1
IAGP
OMIM:166710
MouseDO
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
G
Igf1
insulin-like growth factor 1
treatment
IEP ISO
associated with Diabetes Mellitus, Experimental associated with Cholestasis associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast
RGD
PMID:10499542 PMID:1466160 PMID:19424739 PMID:17647196
RGD:10003127 , RGD:10003132 , RGD:10003131 , RGD:10003128
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
RGD
PMID:18079194
RGD:10045888
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igf2
insulin-like growth factor 2
treatment
ISO
RGD
PMID:12162999
RGD:10402555
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
protein:decreased expression:serum
RGD
PMID:9284698
RGD:10402579
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Il1a
interleukin 1 alpha
ISO
associated with Arthritis, Rheumatoid
RGD
PMID:10555884
RGD:6907107
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:22997530
RGD:7204491
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8182127
RGD:8551834
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il6ra
interleukin 6 receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
G
Irak3
interleukin-1 receptor-associated kinase 3
IAGP
OMIM:166710
MouseDO
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Irs1
insulin receptor substrate 1
ISO
mRNA, protein:decreased expression:multiple
RGD
PMID:22820932
RGD:7207063
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
G
Irs2
insulin receptor substrate 2
ISO
associated with Diabetes Mellitus, Type 2; protein:decreased expression:liver,kidney, muscle:
RGD
PMID:22820932
RGD:7207063
NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458
G
Kl
klotho
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9363890 PMID:9363890
RGD:10403047
NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282
G
Lep
leptin
treatment
ISO
associated with chronic obstructive pulmonary disease; protein:decreased expression:serum human protein in a rat model protein:increased expression:serum (rat)
RGD
PMID:21376149 PMID:11459801 PMID:12609558 PMID:24250662
RGD:5128771 , RGD:10053630 , RGD:10053615 , RGD:10053572
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
susceptibility
ISO
DNA:polymorphisms:cds:p.K109R,Q223R(human)
RGD
PMID:23460508
RGD:10411886
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Lrp5
low density lipoprotein receptor-related protein 5
treatment
ISO
ClinVar Annotator: match by term: LRP5-related primary osteoporosis | ClinVar Annotator: match by term: OSTEOPOROSIS, INVOLUTIONAL | ClinVar Annotator: match by term: Osteoporosis CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 1 | ClinVar Annotator: match by term: LRP5-related primary osteoporosis | ClinVar Annotator: match by term: OSTEOPOROSIS, INVOLUTIONAL | ClinVar Annotator: match by term: Osteoporosis
ClinVar CTD RGD
PMID:9536098 PMID:11719191 PMID:11793484 PMID:12579474 PMID:14727154 PMID:15024691 PMID:15077203 PMID:15141052 PMID:15201508 PMID:15619672 PMID:15767861 PMID:15777745 PMID:15824851 PMID:15824861 PMID:15850991 PMID:16234968 PMID:16252235 PMID:16679074 PMID:17052975 PMID:17137849 PMID:17202888 PMID:17223614 PMID:17306638 PMID:17307038 PMID:17395706 PMID:17505772 PMID:17576681 PMID:18058054 PMID:18349089 PMID:18588671 PMID:18602879 PMID:19324841 PMID:21528003 PMID:22456437 PMID:23441120 PMID:24423337 PMID:24706814 PMID:24715757 PMID:25711638 PMID:25741868 PMID:25920554 PMID:26348019 PMID:26467025 PMID:28192794 PMID:28378289 PMID:28420620 PMID:28492532 PMID:28494495 PMID:29055141 PMID:29168297 PMID:29181528 PMID:30283887 PMID:30452590 PMID:31039433 PMID:33118644 PMID:33939331 PMID:34639175 PMID:34860240 PMID:35106624 PMID:17002564 PMID:22704852 PMID:21977807 More...
RGD:1625350 , RGD:7240519 , RGD:12793063
NCBI chr19:3,634,825...3,736,574
Ensembl chr19:3,634,828...3,736,564
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16648989 PMID:16936800
NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
G
Ly6a
lymphocyte antigen 6 family member A
IAGP
OMIM:166710
MouseDO
NCBI chr15:74,866,726...74,869,880
Ensembl chr15:74,866,726...74,869,880
G
Mapk14
mitogen-activated protein kinase 14
treatment
ISO
RGD
PMID:18442314
RGD:10045965
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mgll
monoglyceride lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 6:88,701,397...88,805,342
Ensembl chr 6:88,701,394...88,805,342
G
Mir152
microRNA 152
ISO
miRNA:increased expression:femur
RGD
PMID:31492082
RGD:21066345
NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
G
Mmp9
matrix metallopeptidase 9
ISO
associated with osteoporosis; protein:increased expression:serum
RGD
PMID:19411568
RGD:5129553
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Myc
myelocytomatosis oncogene
ISO
RGD
PMID:22704852
RGD:7240519
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Nog
noggin
IMP
RGD
PMID:12975477
RGD:10414323
NCBI chr11:89,191,464...89,193,385
Ensembl chr11:89,191,464...89,193,158
G
Nrip1
nuclear receptor interacting protein 1
ISO
DNA:silent mutation, haplotype:p.G75G (human)
RGD
PMID:16530497
RGD:10045825
NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715
G
Opa1
OPA1, mitochondrial dynamin like GTPase
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868
NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
G
Oxct1
3-oxoacid CoA transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:4,055,910...4,184,826
Ensembl chr15:4,055,865...4,184,826
G
P4hb
prolyl 4-hydroxylase, beta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr11:120,451,124...120,464,079
Ensembl chr11:120,451,124...120,464,079
G
Park7
Parkinson disease (autosomal recessive, early onset) 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
G
Pcna
proliferating cell nuclear antigen
ISO
protein:increased expression:osteoblast:
RGD
PMID:22550338
RGD:10045656
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pdlim4
PDZ and LIM domain 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr11:53,945,754...53,959,814
Ensembl chr11:53,945,754...53,959,840
G
Pgls
6-phosphogluconolactonase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 8:72,044,828...72,048,911
Ensembl chr 8:72,044,820...72,053,736
G
Pkm
pyruvate kinase, muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
G
Plek
pleckstrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr11:16,921,206...16,958,718
Ensembl chr11:16,921,206...17,002,381
G
Pls3
plastin 3 (T-isoform)
IAGP
OMIM:166710
MouseDO
NCBI chr X:74,829,259...74,918,788
Ensembl chr X:74,829,260...74,918,788
G
Pnp2
purine-nucleoside phosphorylase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr14:51,193,598...51,202,206
Ensembl chr14:51,193,449...51,202,206
G
Pomc
pro-opiomelanocortin-alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3017235 PMID:4367732 PMID:6143199 PMID:6254450 PMID:19153526
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Prdx3
peroxiredoxin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr19:60,852,504...60,862,976
Ensembl chr19:60,852,489...60,862,994
G
Psma2
proteasome subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr13:14,787,827...14,800,258
Ensembl chr13:14,787,825...14,848,821
G
Psma5
proteasome subunit alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 3:108,164,242...108,187,268
Ensembl chr 3:108,164,242...108,187,290
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
treatment
ISO
RGD
PMID:16442794
RGD:10043381
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Pth
parathyroid hormone
treatment
ISO
CTD Direct Evidence: therapeutic protein:decreased expression:serum (rat)
CTD RGD
PMID:15710971 PMID:17317460 PMID:17882678 PMID:19578808 PMID:21306167 PMID:30639440 PMID:23161222 PMID:22312238 More...
RGD:7242793 , RGD:7242907
NCBI chr 7:112,984,783...112,987,879
Ensembl chr 7:112,984,787...112,987,777
G
Rab7b
RAB7B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 1:131,616,412...131,646,288
Ensembl chr 1:131,616,433...131,643,177
G
Ren1
renin 1 structural
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18847324
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Rsu1
Ras suppressor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 2:13,081,778...13,276,116
Ensembl chr 2:13,081,632...13,276,226
G
Ryr1
ryanodine receptor 1, skeletal muscle
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:28,702,765...28,824,599
Ensembl chr 7:28,702,769...28,824,604
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868 PMID:28492532 PMID:29150909 PMID:30968248
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Sirt1
sirtuin 1
treatment
ISO
RGD
PMID:22555620 PMID:25377437
RGD:10047129 , RGD:10053568
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Sod2
superoxide dismutase 2, mitochondrial
susceptibility no_association
ISO
DNA:SNPs:intron, exon:g.31A>G, g.327C>T (p.A16V) (rs5746094, rs4880) (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:5' utr, exon, intron:multiple
CTD RGD
PMID:18924182 PMID:26336112 PMID:26336112
RGD:11035299 , RGD:11035299
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Terc
telomerase RNA component
IAGP
OMIM:166710
MouseDO
NCBI chr 3:96,321,753...96,322,149
Ensembl chr 3:96,321,753...96,322,149
G
Tgfb1
transforming growth factor, beta 1
treatment
ISO
associated with Uremia;protein:increased expression:osteoblast, osteoclast CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12706579 PMID:17647196
RGD:10003128
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tln1
talin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:43,531,513...43,562,583
Ensembl chr 4:43,531,519...43,562,691
G
Tnfrsf11a
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709
G
Tnfrsf11b
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
ISO IAGP
CTD Direct Evidence: marker/mechanism OMIM:166710
CTD MouseDO
PMID:17667143
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Tnfsf11
tumor necrosis factor (ligand) superfamily, member 11
ISO IAGP
OMIM:166710 CTD Direct Evidence: therapeutic
MouseDO CTD RGD
PMID:17882678 PMID:17002564
RGD:1625350
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
G
Tpi1
triosephosphate isomerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 6:124,787,549...124,791,121
Ensembl chr 6:124,787,549...124,791,259
G
Tpm4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 8:72,889,132...72,906,986
Ensembl chr 8:72,884,018...72,906,986
G
Tuba1b
tubulin, alpha 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:98,829,310...98,832,271
Ensembl chr15:98,829,306...98,832,446
G
Tuba1c
tubulin, alpha 1C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:98,927,772...98,935,986
Ensembl chr15:98,927,772...98,935,991
G
U2af1
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr17:31,866,055...31,878,122
Ensembl chr17:31,866,055...31,877,866
G
Vcl
vinculin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr14:20,979,436...21,083,744
Ensembl chr14:20,979,466...21,083,744
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
no_association
ISO IAGP
associated with Cystic Fibrosis OMIM:166710
MouseDO RGD
PMID:16713399
RGD:4889871
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Wdr1
WD repeat domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 5:38,684,149...38,720,265
Ensembl chr 5:38,684,156...38,720,564
G
Wnt1
wingless-type MMTV integration site family, member 1
ISO
ClinVar Annotator: match by term: OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Osteoporosis CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:23499309 PMID:23656646 PMID:25741868
NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718
G
Zdhhc13
zinc finger, DHHC domain containing 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20548961
NCBI chr 7:48,438,751...48,477,188
Ensembl chr 7:48,438,751...48,477,188
G
F12
coagulation factor XII (Hageman factor)
ISO
ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:24033266 PMID:25050900 PMID:25741868 PMID:28492532 PMID:30943683
NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
G
Slc34a1
solute carrier family 34 (sodium phosphate), member 1
ISO
ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:24033266 PMID:25050900 PMID:25741868 PMID:28492532 PMID:30943683
NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405
G
F12
coagulation factor XII (Hageman factor)
ISO
ClinVar Annotator: match by term: Hypophosphatemic nephrolithiasis/osteoporosis 1
ClinVar
PMID:25050900 PMID:25741868 PMID:28492532 PMID:30943683
NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
G
Slc34a1
solute carrier family 34 (sodium phosphate), member 1
ISO
ClinVar Annotator: match by term: Hypophosphatemic nephrolithiasis/osteoporosis 1 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:9536098 PMID:12324554 PMID:14672348 PMID:16199547 PMID:16688119 PMID:17576681 PMID:21597970 PMID:24033266 PMID:25050900 PMID:25082825 PMID:25296721 PMID:25741868 PMID:26047794 PMID:26272126 PMID:26787776 PMID:27378183 PMID:28492532 PMID:28893421 PMID:29924459 PMID:29959532 PMID:30778725 PMID:30943683 PMID:31672324 PMID:33099630 PMID:33226606 PMID:33536578 PMID:34805638 More...
NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405
G
Slc34a3
solute carrier family 34 (sodium phosphate), member 3
ISO
ClinVar Annotator: match by term: Hypophosphatemic nephrolithiasis/osteoporosis 1
ClinVar
PMID:25741868 PMID:28492532 PMID:31672324
NCBI chr 2:25,118,909...25,124,282
Ensembl chr 2:25,118,910...25,124,376
G
Nherf1
NHERF family PDZ scaffold protein 1
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hypophosphatemic nephrolithiasis/osteoporosis 2
OMIM CTD ClinVar
PMID:18784102 PMID:24033266 PMID:25326635 PMID:25741868 PMID:28492532 PMID:28893421 More...
NCBI chr11:115,054,138...115,072,009
Ensembl chr11:115,054,167...115,072,007
G
Lrp5
low density lipoprotein receptor-related protein 5
ISO
DNA:mutations:exon:c.3446 T > A (p.L1149Q),c.3553 G > A (p.G1185R)(human)
RGD
PMID:22487062
RGD:12793058
NCBI chr19:3,634,825...3,736,574
Ensembl chr19:3,634,828...3,736,564
G
Copb2
COPI coat complex subunit beta 2
ISO
ClinVar Annotator: match by term: Osteoporosis, childhood- or juvenile-onset, with developmental delay
OMIM ClinVar
PMID:25741868 PMID:34450031
NCBI chr 9:98,445,784...98,470,428
Ensembl chr 9:98,445,774...98,470,435
G
Acp5
acid phosphatase 5, tartrate resistant
ISO
protein:increased expression:femur (rat)
RGD
PMID:19736603
RGD:2315910
NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007
G
Ar
androgen receptor
ISO
RGD
PMID:12593895
RGD:1578682
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Bmp15
bone morphogenetic protein 15
susceptibility
ISO
DNA:SNPs, haplotype:5' utr, intron:g.-9C>G, IVS1+905A>G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chr X:6,226,108...6,232,778
Ensembl chr X:6,226,161...6,232,775
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17227729
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Col1a1
collagen, type I, alpha 1
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:2037280 PMID:2542316 PMID:7695699 PMID:7942841 PMID:8218237 PMID:8408653 PMID:8669434 PMID:8808594 PMID:9016532 PMID:9067755 PMID:9295084 PMID:9443882 PMID:10931857 PMID:12590186 PMID:15024692 PMID:15241796 PMID:15864348 PMID:15931785 PMID:16199547 PMID:16879195 PMID:17078022 PMID:17309652 PMID:18412368 PMID:18553566 PMID:18704262 PMID:19344236 PMID:19358256 PMID:21249479 PMID:21567126 PMID:21667357 PMID:22589248 PMID:22753364 PMID:22855962 PMID:24390061 PMID:25086671 PMID:25741868 PMID:25944380 PMID:25963598 PMID:26177859 PMID:26467025 PMID:27509835 PMID:27510842 PMID:27519266 PMID:28378289 PMID:28492532 PMID:28810924 PMID:31447884 PMID:32166892 PMID:33228694 PMID:33928192 PMID:33939306 More...
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col1a2
collagen, type I, alpha 2
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:1463018 PMID:1978725 PMID:2052622 PMID:2985635 PMID:7695699 PMID:7860070 PMID:8094076 PMID:8218237 PMID:8786074 PMID:9016532 PMID:9272740 PMID:9399846 PMID:9594376 PMID:9923651 PMID:15172002 PMID:16705691 PMID:16786509 PMID:16879195 PMID:17078022 PMID:18028452 PMID:19344236 PMID:21520333 PMID:22589248 PMID:22753364 PMID:25326637 PMID:25450603 PMID:25741868 PMID:25944380 PMID:26177859 PMID:26264438 PMID:26307460 PMID:26432670 PMID:26604951 PMID:27011056 PMID:27519266 PMID:28017821 PMID:28492532 PMID:30283887 PMID:32659730 More...
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO
DNA:snps:exon:multiple (human)
RGD
PMID:17118999
RGD:1600860
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Esr1
estrogen receptor 1 (alpha)
treatment susceptibility
ISO
DNA:SNP:intron:IVS1T>C (human) DNA:SNPs, haplotype:intron: (rs2234693, rs9340799) (human)
RGD
PMID:16604479 PMID:16972020
RGD:8158082 , RGD:10045838
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
susceptibility
ISO
DNA:SNP: :-1213T>C (human) DNA:repeat:intron:IVS5-3919(CA)18-26 (human) DNA:SNP, haplotype:3'utr:*39A>G (human)
RGD
PMID:16777502 PMID:17945165 PMID:22335445
RGD:1626507 , RGD:10045847 , RGD:10045849
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Fdps
farnesyl diphosphate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31774873
NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266
G
Fgf23
fibroblast growth factor 23
ISO
protein:increased expression: :
RGD
PMID:24101107
RGD:10044241
NCBI chr 6:127,049,865...127,059,257
Ensembl chr 6:127,049,865...127,058,371
G
Hif1a
hypoxia inducible factor 1, alpha subunit
treatment
ISO IMP
RGD
PMID:24023068 PMID:18067744
RGD:10402191 , RGD:10402540
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Ifitm5
interferon induced transmembrane protein 5
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:22863190 PMID:22863195 PMID:23977282 PMID:25251575 PMID:25741868 PMID:28492532 PMID:28725987 PMID:31099171 PMID:31159867 PMID:32383316 More...
NCBI chr 7:140,528,871...140,530,156
Ensembl chr 7:140,528,871...140,530,204
G
Igf1
insulin-like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:11063288
RGD:10045861
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf2
insulin-like growth factor 2
treatment
ISO
RGD
PMID:16753016
RGD:10402556
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il7
interleukin 7
treatment
IEP
RGD
PMID:23662133
RGD:10402930
NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820
G
Lrp5
low density lipoprotein receptor-related protein 5
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:24715757 PMID:25741868 PMID:28492532
NCBI chr19:3,634,825...3,736,574
Ensembl chr19:3,634,828...3,736,564
G
Nfatc1
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1
treatment
ISO
RGD
PMID:31399090
RGD:329328926
NCBI chr18:80,649,418...80,756,286
Ensembl chr18:80,649,420...80,756,286
G
Nrip1
nuclear receptor interacting protein 1
susceptibility
ISO
DNA:silent mutation:cds:p.G75G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715
G
Pgghg
protein glucosylgalactosylhydroxylysine glucosidase
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:22863190 PMID:22863195 PMID:23977282 PMID:25251575 PMID:25741868 PMID:28492532 PMID:28725987 PMID:31099171 PMID:31159867 PMID:32383316 More...
NCBI chr 7:140,521,304...140,527,577
Ensembl chr 7:140,521,304...140,527,577
G
Pls3
plastin 3 (T-isoform)
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:25741868
NCBI chr X:74,829,259...74,918,788
Ensembl chr X:74,829,260...74,918,788
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
treatment
ISO
RGD
PMID:11917107
RGD:10003045
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Pth
parathyroid hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20567999
NCBI chr 7:112,984,783...112,987,879
Ensembl chr 7:112,984,787...112,987,777
G
Ptk2b
PTK2 protein tyrosine kinase 2 beta
ISO
RGD
PMID:17537919
RGD:1642610
NCBI chr14:66,390,706...66,518,549
Ensembl chr14:66,390,706...66,518,501
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10750555
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
treatment
ISO
DNA:SNP:exon: (rs2228570) (human)
GAD RGD
PMID:15118671 PMID:16604479
RGD:1331525 , RGD:8158082
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Ifih1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599
G
Ifih1
interferon induced with helicase C domain 1
ISO
ClinVar Annotator: match by term: Singleton-Merten syndrome 1
OMIM ClinVar
PMID:9536098 PMID:16199547 PMID:17576681 PMID:21070929 PMID:24686847 PMID:24995871 PMID:25620204 PMID:25741868 PMID:26284909 PMID:26833990 PMID:27477329 PMID:28319323 PMID:28475458 PMID:28492532 PMID:28605144 PMID:28606988 PMID:28716935 PMID:29018476 PMID:29270977 PMID:30219631 PMID:30564185 PMID:30707351 PMID:31069529 PMID:31178897 PMID:31898846 PMID:33440462 PMID:34185153 PMID:34539730 PMID:35754802 More...
NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599
G
Rigi
RNA sensor RIG-I
ISO
ClinVar Annotator: match by term: Singleton-Merten syndrome 2
OMIM ClinVar
PMID:25620203 PMID:25741868 PMID:28180316 PMID:28492532
NCBI chr 4:40,203,775...40,239,843
Ensembl chr 4:40,203,773...40,239,828
G
Lpcat2
lysophosphatidylcholine acyltransferase 2
ISO
ClinVar Annotator: match by term: Winchester-Grossman syndrome
ClinVar
NCBI chr 8:93,581,948...93,645,907
Ensembl chr 8:93,581,967...93,645,907
G
Mmp14
matrix metallopeptidase 14 (membrane-inserted)
ISO
ClinVar Annotator: match by term: Winchester syndrome CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:4238825 PMID:17480005 PMID:22922033 PMID:25741868 PMID:29741626
NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821
G
Mmp2
matrix metallopeptidase 2
ISO
ClinVar Annotator: match by term: Winchester-Grossman syndrome
ClinVar
PMID:2625626 PMID:6525336 PMID:9536098 PMID:10356396 PMID:11431697 PMID:15691365 PMID:16458924 PMID:16542393 PMID:17059372 PMID:17576681 PMID:19019335 PMID:20617897 PMID:20673868 PMID:21421877 PMID:23313298 PMID:23378725 PMID:25600631 PMID:25704319 PMID:25741868 PMID:27182040 PMID:28492532 More...
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
disease
18302
Diseases of the Aged
1283
osteoporosis
145
Amino Aciduria with Mental Deficiency, Dwarfism, Muscular Dystrophy, Osteoporosis, and Acidosis
0
Diabetic Bone Disease
0
Female Athlete Triad Syndrome
0
Growth Failure, Microcephaly, Mental Retardation, Cataracts, Large Joint Contractures, Osteoporosis, Cortical Dysplasia, and Cerebellar Atrophy
0
Hernandez Fragoso Syndrome
0
Infantile Multisystem Neurologic Disease with Osseous Fragility
0
Macroepiphyseal Dysplasia, McAlister Coe Type
0
Osteoporosis, Childhood- or Juvenile-Onset, with Developmental Delay
1
Postmenopausal Osteoporosis
29
Prader-Willi Habitus, Osteopenia, and Camptodactyly
0
Premature Aging, Okamoto Type
0
Singleton Merten Syndrome +
2
Winchester syndrome
3
glucocorticoid-induced osteoporosis
0
hypophosphatemic nephrolithiasis/osteoporosis +
4
idiopathic juvenile osteoporosis
1
Path 2
disease
18302
disease of anatomical entity
15634
Skin and Connective Tissue Diseases
6948
connective tissue disease
5397
bone disease
3902
bone remodeling disease
298
bone resorption disease
188
osteoporosis
145
Amino Aciduria with Mental Deficiency, Dwarfism, Muscular Dystrophy, Osteoporosis, and Acidosis
0
Diabetic Bone Disease
0
Female Athlete Triad Syndrome
0
Growth Failure, Microcephaly, Mental Retardation, Cataracts, Large Joint Contractures, Osteoporosis, Cortical Dysplasia, and Cerebellar Atrophy
0
Hernandez Fragoso Syndrome
0
Infantile Multisystem Neurologic Disease with Osseous Fragility
0
Macroepiphyseal Dysplasia, McAlister Coe Type
0
Osteoporosis, Childhood- or Juvenile-Onset, with Developmental Delay
1
Postmenopausal Osteoporosis
29
Prader-Willi Habitus, Osteopenia, and Camptodactyly
0
Premature Aging, Okamoto Type
0
Singleton Merten Syndrome +
2
Winchester syndrome
3
glucocorticoid-induced osteoporosis
0
hypophosphatemic nephrolithiasis/osteoporosis +
4
idiopathic juvenile osteoporosis
1